newsfilter
← Latest News
PR Newswire·

Medivir reports promising interim data, including a first complete response in phase 1b/2a HCC study with fostrox in combination with Lenvima

Central review of the 6 patients in phase 1b dose escalation part was performedIn these 6 patients, complete response was recorded in 1 patient, partial response in 2 patients, and stable disease in 2 patients read by an